Purpose: The first aim of this study was to compare the detectability of metastasis of postoperative differentiated thyroid cancer (DTC) among (131)I whole body scintigraphy (IWBS), fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT), and diffusion-weighted magnetic resonance imaging (DWI). The second aim was to clarify the association between the image pattern and prognosis.
Materials And Methods: We evaluated 70 postoperative DTC patients on both a patient basis and an organ basis (lymph nodes, lung, bone), and we analyzed the correlation between the image pattern and the prognosis.
Results: For the patient-basis analysis, the detectability by IWBS, PET/CT, and DWI was 67.1%, 84.2%, and 57.6%, respectively. IWBS provided complementary information to that provided by PET/CT in 11 of 70 (15.7%) cases. For the organ-basis analysis, IWBS was the best detector for lymph node metastasis (72.4%). PET/CT was superior to IWBS for detecting metastasis of bone (85.7% vs. 71.4%) and lung (94.1% vs. 62.7%). For the correlation analysis, PET and DWI positivity were the factors predicting a poor prognosis.
Conclusion: PET/CT was the best modality for detecting metastases in postoperative DTC patients, although IWBS provided complementary information. Because PET/CT and DWI gave similar information (e.g., positivity) suggesting poor prognoses, the combination of IWBS and DWI might be the method of choice for monitoring postoperative DTC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11604-011-0572-z | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The necessity of thyroid-stimulating hormone suppression therapy for low-risk differentiated thyroid carcinoma following hemithyroidectomy: A systematic review and meta-analysis.
Heliyon
December 2024
Department of Head and Neck Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Background And Objective: Thyroidectomy, followed by postoperative thyroid-stimulating hormone (TSH) suppression therapy, is the established therapeutic approach for low-risk differentiated thyroid carcinoma (DTC). Recently, there has been a growing body of research dedicated to postoperative TSH suppression therapy in low-risk DTC. This study aims to conduct a comprehensive literature review concerning the necessity of TSH suppression therapy in DTC after hemithyroidectomy.
View Article and Find Full Text PDFDetermination of effective half-life of I in thyroid cancer patients using remote dose-rate meter.
EJNMMI Phys
November 2024
Department of Clinical Physiology, Nuclear Medicine, Turku PET Centre, and Medical Physics, Turku University Hospital and Wellbeing Services County of Southwest Finland, Turku, Finland.
Article Synopsis
- The study analyzed external dose-rate signals from remote dose-rate meters (DRMs) in differentiated thyroid cancer (DTC) patients to understand the excretion of radioactive iodine (RAI) post-treatment.
- It involved 110 patients monitored during hospitalization, revealing that the median effective half-life (T) of iodine was 12.60 hours and that higher BMI, lower GFR, and diabetes were linked to longer T values.
- The research concluded that remote DRMs are effective for monitoring radiation levels and can help optimize hospital isolation periods, enhancing both patient comfort and staff efficiency.
The impact of qualitative [18F]FDG PET/CT in predicting clinical outcomes of post-surgical differentiated thyroid cancer patients with elevated thyroglobulin and negative radioiodine whole-body scan.
BMC Surg
November 2024
Department of Nuclear Medicine, Tran Hung Dao Hospital (Hospital 108), Hanoi, Vietnam.
Background: [F]FDG PET/CT has been widely used as a diagnostic tool in detection and localization of recurrent non-avid radioiodine lesions in post-operative differentiated thyroid cancer (DTC) patients with elevated serum thyroglobulin but negative radioiodine whole-body scan (TENIS) syndrome. The aim of our study was to evaluate the role of [F]FDG PET/CT in prediction on outcomes of these DTC patients.
Methods: Post-operative DTC patients with TENIS syndrome were collected in the department of nuclear medicine, Hospital 108 from 2019 to 2023.
Predictive value of thyroglobulin after radioiodine therapy for excellent response to treatment in postoperative thyroid cancer.
Nucl Med Commun
November 2024
Department of Nuclear Medicine.
Objective: This study aimed to assess the usefulness of thyroglobulin (Tg) after radioiodine (RAI) therapy in predicting excellent response (ER) to therapy in postoperative differentiated thyroid cancer (DTC).
Methods: A retrospective observational study was conducted on postoperative DTC patients who underwent RAI from August 2018 to December 2022. Various factors were analyzed to predict ER to treatment.
Relative burden of cancer and noncancer mortality among long-term survivors of differentiated thyroid cancer in the US.
Front Endocrinol (Lausanne)
November 2024
Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, China.
Background: Limited information is available regarding the relative risks of cancer-specific mortality and noncancer-specific mortality among long-term survivors with differentiated thyroid cancer (DTC).
Methods: In this retrospective study, nationwide data from the Surveillance, Epidemiology, and End Results database (1992-2020) were utilized. The Accelerated Failure Time Model was applied to calculate Survival Time Ratios (TR), with the primary focus on mortality resulting from DTC.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!